Yervoy (ipilimumab) does not have a publicly listed "promotional offer" with a specific duration, as it's a Bristol Myers Squibb immunotherapy drug for melanoma and other cancers, typically accessed via insurance, patient assistance programs, or standard pricing rather than time-limited promotions.
How do patients usually get Yervoy at a discount?
BMS runs the Yervoy Copay Card program through a third-party vendor, offering eligible commercially insured patients copay assistance down to $0 (up to $15,000 per year). This isn't a limited-time promo—it's ongoing as long as patients qualify (U.S. residents, no government insurance). Apply at yervoy.com or call 1-855-937-8659.[1]
What's the Access Support program for uninsured patients?
Uninsured or underinsured patients can get Yervoy free through BMS Access Support if they meet income criteria (e.g., household income ≤500% federal poverty level). No expiration date; it's a bridge program while enrolling in other aid. Contact 1-800-861-0048.[1][2]
Any manufacturer coupons or current deals?
No active time-bound promotional offers appear on BMS sites or DrugPatentWatch. Past copay cards have renewed annually without fixed end dates. Check yervoy.com/savings for updates, as terms can change.[3]
How does pricing work without promotions?
List price is about $184,000 for a full treatment course (four infusions), but net prices drop 40-60% after rebates. Generic versions don't exist yet due to patents expiring around 2028-2035.[4]
Sources:
[1] Yervoy.com patient support
[2] BMS Access Support
[3] Yervoy HCP savings
[4] DrugPatentWatch.com - Yervoy patents